Investors Are Waking Up To Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) After Rising 8.24% Over The Past 12 Months

Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) currently has a daily average trading volume of 994.49K but it saw 1608263 shares traded in last market. With a market cap of 12.12B USD, the company’s current market price of $14.55 came rising about 0.48 while comparing to the previous closing price of $14.48. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.89 and as low as $13.26. In the recent trading on the day, stock has struck highest price mark of $14.525 while lowest mark touched by it was $14.87.

Taking a look at 20-day trading activity of Dr. Reddy’s Laboratories Ltd. ADR (RDY) gives us an average price of $14.34, while its current price level is -13.86% below from 52-week high level whereas it is 9.70% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $14.85 while that of 200 days or SMA-200 reads an average of $15.12. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.40% during that period while stretching the period over a month that decreases to 1.36%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 50.50 which implies that the stock is in neutral territory.

Over the week, RDY’s stock price is moving 0.62% up while it is 3.19% when we observe its performance for the past one month. Year-to-date it is 4.56% up and over the past year, the stock is showing an upside performance of 8.24%.

Currently, Dr. Reddy’s Laboratories Ltd. ADR’s total number of outstanding shares is 834.38M. Company’s return on investment (ROI) stands at 17.14% and return on equity (ROE) at 19.12%. It has a price to earnings ratio (P/E ratio) of 18.97 while having a 17.86 of forward P/E ratio. Stock’s beta reads 0.53. Stock has a price to book (P/B) ratio of 3.33 while price to sale or P/S ratio amounts to 3.37. Its return on asset (ROA) is 13.14% on average.